Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001415889-25-002269

Options or other derivatives

  • Chief Operating Officer acquired 201,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Nelson Jeffrey Edward Chief Operating Officer 2025-01-27 Grant or award · Employee Stock Option (right to buy) +120,600 120,600 D
Nelson Jeffrey Edward Chief Operating Officer 2025-01-27 Grant or award · Restricted Stock Unit +80,400 80,400 D
Loading xslF345X05/form4-01292025_040113.xml…